Article Information
History
- January 24, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Juana Claus, MSc1,
- Thijs ten Doesschate, PhD1,2,
- Esther Taks, MD3,
- Priya Debisarun, MD3,
- Gaby Smits, MSc4,
- Rob van Binnendijk, PhD4,
- Fiona van der Klis, PhD4,
- Lilly M. Verhagen, PhD5,6,
- Marien I. de Jonge, PhD6,
- Marc J.M. Bonten, PhD1,
- Mihai G. Netea, PhD3,7 and
- Janneke H. H. M. van de Wijgert, PhD1,4,*
- 1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
- 2Department of Internal Medicine, Jeroen Bosch Ziekenhuis, ‘s Hertogenbosch, Netherlands
- 3Department of Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands
- 4National Institute of Public Health and the Environment, Bilthoven, Netherlands
- 5Department of Paediatric Infectious Diseases and Immunology, Amalia Children’s Hospital, Radboud University Medical Center, Nijmegen, Netherlands
- 6Department of Laboratory Medicine, Laboratory of Medical Immunology, Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, Netherlands
- 7Department for Genomics & Immunoregulation, Life and Medical Sciences Institute, University of Bonn, Germany
- ↵*Corresponding Author: Janneke van de Wijgert Julius Center for Health Sciences and Primary Care University Medical Center Utrecht Universiteitsweg 100, 3584 CG Utrecht Email: j.h.h.vandewijgert{at}umcutrecht.nl
Posted January 24, 2024.
Systemic SARS-CoV-2-specific antibody responses to infection and to COVID-19 and BCG vaccination
